Stocks and Investing Stocks and Investing
Mon, March 14, 2016
Sun, March 13, 2016
Fri, March 11, 2016
Thu, March 10, 2016
Wed, March 9, 2016

Konstantinos Aprilakis Maintained (BPMC) at Buy with Decreased Target to $37 on, Mar 9th, 2016


Published on 2024-10-25 11:51:58 - WOPRAI, Konstantinos Aprilakis
  Print publication without navigation


Konstantinos Aprilakis of JMP Securities, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $54 to $37 on, Mar 9th, 2016.

Konstantinos, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources